shRNA-resistant wild-type ASAH1 rescued tumor growth in the melanoma cell line expressing ASAH1 shRNA, whereas the shRNA-resistant enzymatically defective ASAH1 mutant did not (Figure 2D,E and Supplementary Fig. 3C). This evidence concerns the gene ASAH1 and melanoma.